Giant Biogene Holding Co., a prominent player in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in the early 2000s, the company has achieved significant milestones, establishing itself as a leader in genetic research and biopharmaceuticals. Specialising in innovative gene editing technologies and advanced therapeutics, Giant Biogene's core products are distinguished by their precision and efficacy, catering to both medical and agricultural applications. The company’s commitment to research and development has positioned it favourably in the competitive biotech landscape, earning recognition for its contributions to sustainable solutions and health advancements. With a robust market presence, Giant Biogene continues to drive progress in the industry, reflecting its dedication to improving lives through biotechnology.
How does Giant Biogene Holding Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Giant Biogene Holding Co's score of 27 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Giant Biogene Holding Co reported total carbon emissions of approximately 6,445,410 kg CO2e. This figure includes 1,505,670 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 4,939,740 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, the company reported 1,827,340 kg CO2e in Scope 3 emissions, which encompass all other indirect emissions in the value chain, specifically from purchased goods and services. In 2022, the company’s total emissions were about 4,407,200 kg CO2e, with Scope 1 emissions at 1,058,090 kg CO2e and Scope 2 emissions at 3,349,110 kg CO2e. This indicates a significant increase in emissions from 2022 to 2023. Despite the increase in emissions, there are currently no publicly disclosed reduction targets or climate pledges from Giant Biogene Holding Co. The absence of specific reduction initiatives suggests that the company may be in the early stages of developing a comprehensive climate strategy. As the industry increasingly focuses on sustainability, it will be crucial for Giant Biogene to establish clear commitments to reduce its carbon footprint in the future.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2022 | 2023 | |
---|---|---|
Scope 1 | 1,058,090 | 0,000,000 |
Scope 2 | 3,349,110 | 0,000,000 |
Scope 3 | - | 0,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Giant Biogene Holding Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.